Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
PL Porter, KE Malone, PJ Heagerty, GM Alexander… - Nature medicine, 1997 - nature.com
PL Porter, KE Malone, PJ Heagerty, GM Alexander, LA Gatti, EJ Firpo, JR Daling…
Nature medicine, 1997•nature.comMutations in certain genes that regulate the cell cycle, such as p16 and p53, are frequently
found in human cancers1. However, tumor-specific mutations are uncommon in genes
encoding cyclin E and the CDK inhibitor p27Kip1, two cell-cycle regulators that are also
thought to contribute to tumor progression2–8. It is now known that levels of both cyclin E
and p27 can be controlled by posttranscriptional mechanisms, indicating that expression of
these proteins can be altered by means other than simply mutation of their respective …
found in human cancers1. However, tumor-specific mutations are uncommon in genes
encoding cyclin E and the CDK inhibitor p27Kip1, two cell-cycle regulators that are also
thought to contribute to tumor progression2–8. It is now known that levels of both cyclin E
and p27 can be controlled by posttranscriptional mechanisms, indicating that expression of
these proteins can be altered by means other than simply mutation of their respective …
Abstract
Mutations in certain genes that regulate the cell cycle, such as p16 and p53, are frequently found in human cancers1. However, tumor-specific mutations are uncommon in genes encoding cyclin E and the CDK inhibitor p27Kip1, two cell-cycle regulators that are also thought to contribute to tumor progression2–8. It is now known that levels of both cyclin E and p27 can be controlled by posttranscriptional mechanisms, indicating that expression of these proteins can be altered by means other than simply mutation of their respective genes9,10. Thus, changes in p27 and cyclin E protein levels in tumors might be more common than previously anticipated and may be indicators of tumor behavior.
nature.com